Quantcast

Latest Complete blood count Stories

2014-06-24 23:05:29

GIA announces the release of a comprehensive global report on Hematology Instruments and Reagents markets. Global market for hematology instruments and reagents is projected to reach US$6.9 billion by 2020, driven by aging population, increasing prevalence of chronic conditions, trend towards early disease diagnosis, strong demand for automated and high-throughput analyzers, and increasing adoption of POC devices. San Jose, California (PRWEB) June 24, 2014 Follow us on LinkedIn....

2014-04-21 12:27:29

SUNNYVALE, Calif., April 21, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that data from the Phase III PCYC-1112 (RESONATE(TM)) study of single agent IMBRUVICA(TM) (ibrutinib) vs. ofatumumab, an established therapy in relapsed refractory CLL, as well as data from an Independent Efficacy Evaluation of IMBRUVICA after three years of follow-up, will be presented at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting in Chicago, Illinois May 30 - June...

2014-03-31 12:28:26

New Italian data uncover specific association between diet and blood cell markers of heart attack- and stroke-associated inflammation WASHINGTON, March 31, 2014 /PRNewswire-USNewswire/ -- New research further illuminates the heart-healthy benefits of the Mediterranean diet, tying the eating plan to lower levels of platelets and white blood cells, two markers of inflammation. Inflammation has an association with greater risk of heart attack and stroke. Study results are published...

2014-02-12 16:25:59

HORSHAM, Pa., Feb. 12, 2014 /PRNewswire/ -- Janssen Biotech, Inc. ["Janssen"] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA(TM) (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.(1) IMBRUVICA was first approved in November 2013 for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.(1) Both indications are based...

2014-02-12 12:32:40

SUNNYVALE, Calif., Feb. 12, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA((TM)) (ibrutinib) as a single agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.(1) This indication is based on overall response rate (ORR). An improvement in survival or disease-related symptoms has not been established.(1) IMBRUVICA is the first...

2014-02-08 23:02:29

Parkway Pet Clinic is an affordable San Diego veterinarian hospital that recently added a state of the art in-house laboratory offering professional blood work services. Escondido, CA (PRWEB) February 08, 2014 Parkway Pet Clinic highly recommends blood work as an integral part of your pet's annual exam. Aside from helping diagnose disease at the earliest possible time, it can also help you avoid expensive medical bills. Unlike people, pets are unable to say how they are feeling. When...

2013-10-30 15:46:31

Abnormalities in particular white blood cells hold key to findings Researchers from the University of Missouri School of Medicine have found a more accurate method to screen for bacterial meningococcal infection in its early stages, when it's hardest to detect. According to the researchers, the method for diagnosis could save lives by getting patients treatment earlier, when the infection is most treatable. While meningococcal infection is relatively rare, affecting approximately 2,500...

2013-09-04 23:03:51

Medical Food Designed to Address the Increased Nutritional Requirements of Anemia Los Angeles, CA (PRWEB) September 04, 2013 Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the company has initiated a third open-label clinical trial of its oral amino acid-based erythropoietin stimulating system (ESS) to determine increased red blood cell production in subjects diagnosed with anemia of chronic disease. The study consists of 30 patients randomized for treatment across...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related